SRx Health acquires SRx Canada; FY2024 net loss C$59.4M, goodwill impairment C$26.9M, going concern doubt

SRx Health Solutions, Inc.

SRx Canada revenue C$200.5M for year ended Sep 30, 2024, net loss C$59.4M vs loss C$15.1M prior year.
Goodwill impairment C$26.9M and intangibles impairment C$2.1M recorded in FY2024.
Auditor's report includes material uncertainty about going concern due to net capital deficiency of C$72.0M.
As of Sep 30, 2024, total liabilities C$117.6M exceed total assets C$45.6M.
Pro forma combined financials filed; business combination closed Apr 24, 2025, with SRx Canada as surviving entity.

item 9.01item 1.01item 2.01item 5.01item 5.02item 5.03item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.